Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Grinnan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
American Journal of Respiratory and Critical Care Medicine|June 17, 2014
Treatment of group I pulmonary arterial hypertension with carvedilol is safeDaniel Grinnan, Harm-Jan Bogaard, John Grizzard, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 23, 2022
Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR)Jonah D Garry, Nicholas A Kolaitis, Richard Kronmal, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2018
IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot StudyCory R Trankle, Justin M Canada, Dinesh Kadariya, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2025
The landscape of referrals for lung transplantation in pulmonary arterial hypertension: A report from the Pulmonary Hypertension Association RegistryNicholas A Kolaitis, Jonathan P Singer, Sonja Bartolome, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 26, 2026
Corrigendum to 'The landscape of referrals for lung transplantation in pulmonary arterial hypertension: A report from the Pulmonary Hypertension Association Registry'[J Heart Lung Transplant, 45 (2026) 125-136]Nicholas A Kolaitis, Jonathan P Singer, Sonja Bartolome, et al.
Annals of the American Thoracic Society|July 30, 2020
A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of CareJoshua D Lee, Charles D Burger, Genecelle B Delossantos, et al.
American Journal of Respiratory and Critical Care Medicine|November 19, 2020
Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association RegistryJeff Min, David Badesch, Murali Chakinala, et al.
Annals of the American Thoracic Society|March 3, 2022
Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association RegistryRoberto J Bernardo, Di Lu, Ramon L Ramirez, et al.
Pulmonary Circulation|November 26, 2020
Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association RegistryShoaib Fakhri, Kelly Hannon, Kelly Moulden, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
American Journal of Respiratory and Critical Care Medicine|June 17, 2014
Treatment of group I pulmonary arterial hypertension with carvedilol is safeDaniel Grinnan, Harm-Jan Bogaard, John Grizzard, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 23, 2022
Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR)Jonah D Garry, Nicholas A Kolaitis, Richard Kronmal, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2018
IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot StudyCory R Trankle, Justin M Canada, Dinesh Kadariya, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2025
The landscape of referrals for lung transplantation in pulmonary arterial hypertension: A report from the Pulmonary Hypertension Association RegistryNicholas A Kolaitis, Jonathan P Singer, Sonja Bartolome, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 26, 2026
Corrigendum to 'The landscape of referrals for lung transplantation in pulmonary arterial hypertension: A report from the Pulmonary Hypertension Association Registry'[J Heart Lung Transplant, 45 (2026) 125-136]Nicholas A Kolaitis, Jonathan P Singer, Sonja Bartolome, et al.
Annals of the American Thoracic Society|July 30, 2020
A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of CareJoshua D Lee, Charles D Burger, Genecelle B Delossantos, et al.
American Journal of Respiratory and Critical Care Medicine|November 19, 2020
Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association RegistryJeff Min, David Badesch, Murali Chakinala, et al.
Annals of the American Thoracic Society|March 3, 2022
Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association RegistryRoberto J Bernardo, Di Lu, Ramon L Ramirez, et al.
Pulmonary Circulation|November 26, 2020
Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association RegistryShoaib Fakhri, Kelly Hannon, Kelly Moulden, et al.
Pageof 2